TrialEuropean heart journal2016

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.

C Noel Bairey Merz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.